ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,331Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 212

$1.02M Total Retail Price of All Prescriptions

Rank: 3 out of 212

541 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 13,792 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 621 606 1 1
LISINOPRIL 621 596 1 2
FUROSEMIDE 552 538 3 11
LOSARTAN POTASSIUM 432 422 4 4
NAMENDA 405 405 5 28
OMEPRAZOLE 379 351 6 9
MIRTAZAPINE 346 346 7 43
DONEPEZIL HCL 345 345 8 25
LEVOTHYROXINE SODIUM 344 338 9 7
ATORVASTATIN CALCIUM 297 297 10 6
LACTULOSE 285 257 11 70
METFORMIN HCL 258 228 12 5
METOPROLOL TARTRATE 247 223 13 17
ATENOLOL 233 233 14 13
POTASSIUM CHLORIDE 226 214 15 27
AMLODIPINE BESYLATE 216 213 16 3
GEMFIBROZIL 207 195 17 79
LOVASTATIN 203 203 18 12
ALENDRONATE SODIUM 195 180 19 16
NIFEDIAC CC 170 165 20 76
RANITIDINE HCL 158 158 21 29
WARFARIN SODIUM 142 142 22 19
TAMSULOSIN HCL 142 138 22 21
CITALOPRAM HBR 135 133 24 56
METOPROLOL SUCCINATE 134 134 25 14
HYDROCHLOROTHIAZIDE 132 132 26 8
HYDROCODONE-ACETAMINOPHEN 127 110 S3 27 10
NIFEDIPINE ER 127 126 27 77
CARVEDILOL 124 124 29 23
ACTOS 114 114 30 68
PRAVASTATIN SODIUM 111 111 31 15
ZOLPIDEM TARTRATE 104 87 32 26
PRANDIN 98 96 33 135
GABAPENTIN 97 86 34 22
DOXYCYCLINE HYCLATE 96 93 35 90
EVISTA 95 95 36 49
CLOPIDOGREL 93 93 37 31
LOSARTAN-HYDROCHLOROTHIAZIDE 92 91 38 20
ALLOPURINOL 92 92 38 18
PANTOPRAZOLE SODIUM 90 90 40 44
CALCITONIN-SALMON 89 89 41 134
DIGOXIN 88 88 42 41
JANUVIA 84 84 43 35
SPIRIVA 81 81 44 45
ONGLYZA 81 81 44 140
PAROXETINE HCL 81 71 44 142
ESCITALOPRAM OXALATE 81 77 44 98
EXELON 79 79 48 86
BACLOFEN 79 45 48 143
CELEBREX 78 78 50 42
PRADAXA 74 74 51 169
TRICOR 72 72 52 170
LANTUS 72 72 52 103
AVELOX 72 71 52 170
PLAVIX 72 68 52 54
DIOVAN 69 69 56 32
PREDNISONE 68 68 57 46
TRAMADOL HCL 68 66 57 50
PRAMIPEXOLE DIHYDROCHLORIDE 61 61 59 185
CARBIDOPA-LEVODOPA 59 58 60 147
TRAZODONE HCL 56 44 61 52
MUPIROCIN 54 51 62 195
POLYETHYLENE GLYCOL 3350 53 52 63 91
ACTONEL 52 52 64 73
FELODIPINE ER 51 39 65 36
LIPITOR 50 50 66 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.